Scientists are excitedly examining retatrutide, a novel drug created by Eli Lilly, as a potential breakthrough in body loss . Distinct from many earlier approaches, retatrutide is a twin-action receptor targeting simultaneously GLP-1 and GIP, chemicals that influence hunger and blood sugar contr… Read More